The Russian Pharmaceuticals & Healthcare Market Is Expected to Increase by 10.5% in 2007.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c55702) has announced the addition of Russia Pharmaceuticals & Healthcare Report Q4 2006 to their offering. The Russia Pharmaceuticals & Healthcare Report provides independent forecasts and competitive intelligence on Russia's pharmaceuticals & healthcare industry. At the end of 2006, Russia remained one of the most dynamic of the large pharmaceutical markets in the world, but recent policy moves by the government have taken some of the shine of the market, impacting BMI's previous growth forecast going forward. The government's decision in October 2006 to severely cut the number of higher priced, imported medicines covered by the DLO DLO abbr. dead letter office DLO n abbr (= dead-letter office) → oficina de Correos que se encarga de las cartas que no llegan a su destino reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. scheme will hit market numbers in 2007. A decline in the value of the US dollar versus the rouble ROUBLE. The name of a coin. The rouble of Russia, as money of account, is deemed and taken at the custom-house, to be of the value of seventy-five cents. Act March 3, 1843. , from 27.7 in 2006 to 26.0 in 2007, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. forecasts by BMI's Country Risk Service, will mask the slowdown For articles with similar titles, see Slow Down (disambiguation). A slowdown is an industrial action in which employees perform their duties but seek to reduce productivity or efficiency in their performance of these duties. in dollar terms. However, it also will encourage the government to tighten prices in the DLO system, as happened in March 2006, when the government introduced across-the-board price cuts for medicines. On top of these developments, a major corruption scandal unfolded in November 2006, forcing the resignation of the minister of health and posing serious questions about the management of DLO and insurance funds. We forecast 10.5% market growth in 2007, compared to more than 20% in 2006 and 33% in 2005. Market growth is expected to steady at 10% per annum Per annum Yearly. between 2008 and 2010. The Russian government says at least 30% of DLO spending will go to domestically produced medicines, although many in the market dispute whether the local market will be able to replace many of the high-priced, research-based medicines that have been eliminated from the programme. Still, there is some good news -- Russia appears set to liberalise Verb 1. liberalise - become more liberal; "The laws liberalized after Prohibition" liberalize change - undergo a change; become different in essence; losing one's or its original nature; "She changed completely as she grew older"; "The weather changed last the insurance market as part of its deal securing US support for World Trade Organisation (WTO See World Trade Organization. ) accession Coming into possession of a right or office; increase; augmentation; addition. The right to all that one's own property produces, whether that property be movable or immovable; and the right to that which is united to it by accession, either naturally or artificially. , allowing foreign insurers to operate independently in the Russian market for the first time. This will drive growth in the Russian market for private health insurance and greater consumption of imported medicines, in part countering the decline in DLO spending. Much of the rest of the market should be buoyed by out-of-the-pocket spending as Russia's GDP GDP (guanosine diphosphate): see guanine. continues to grow, expected to average 5.6% between 2006 and 2010. The mergers and acquisitions deal flow continued in Russia during Q406, although at a slower rate than previously anticipated, perhaps due to uncertainty over the DLO and the need to carefully vet vet common idiomatic version of veterinarian. acquisition targets as Russia's private pharmaceutical industry has been historically less transparent than other consumer sectors in Russia. One of the biggest deals to date was the November 2006 EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 47mn (US$61mn) acquisition of a 51% stake in local producer Zdrovje by Icelandic generics maker Actavis. Speculation continued that the controlling shareholder local player Akrikhin continued to explore a possible sale and 'cooperation' talks with Indian generics giant Ranbaxy were reportedly ongoing. On the pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent. retail front, leading domestic distributor Protek acquired the OZ chain in early December, combining it with its existing Rigla chain to create the country's second largest pharmacy network. Heightened regulatory risk and a downgrade Downgrade A negative change in the rating of a security. Notes: For example, an analyst may downgrade a stock from strong buy to buy, or a bond rating agency may downgrade a bond from AAA to AA. in Russia's growth forecast mean Russia has dropped from first to fourth in BMI's updated Business Environment Rankings for the 14 leading markets in the Central and Eastern European region. In 2007, it will be government policy and its consistency (or lack thereof) that will determine whether Russia's pharmaceutical market growth can be sustained in double digits Double Digits was a pricing game on the American television game show, The Price Is Right. Played from April 20, 1973 through May 18, 1973's show, it was played for a car and used small prizes. . Topics Covered Executive Summary Russia Pharmaceuticals & Healthcare Industry SWOT Russia Political SWOT Russia Economic SWOT Russia Business Environment SWOT Russia: Business Environment Ranking Business Environment Ranking Economics - Long-Term Risk Politics - Long-Term Risk Regulatory Barriers Domestic Sector Threat Market Growth Potential Market Size Ranking Russia: Market Summary Regulatory Regime Intellectual Property Environment Pricing & Reimbursement Issues Industry Developments Industry Forecast Scenario Overall Market Forecast Table: Russia Drug Market Expenditure Forecasts Key Growth Factors - Industry Key Growth Factors - Macroeconomic Table: Growth And Output Prescription Market Forecast Table: Russia Prescription Market Forecasts OTC Market Forecast Table: Russia OTC Market Forecasts Generics Market Forecast Table: Generics Market Forecasts Table: Russia Pharmaceuticals Exports & Imports Forecasts Other Healthcare Data Forecasts Table: Russia Healthcare Data Forecasts Key Risks To BMI's Forecast Scenario Competitive Landscape Wholesale Sector Retail Sector Table: Pharmacies & Pharmacy Market Ratios Company Monitor Berlin-Chemie/Menarini Pharma GmbH Gedeon Richter Krka Lek (Novartis/Sandoz) Verofarm BMI Forecast Modelling How We Generate Our Industry Forecasts Technical Process Pharmaceutical Industry Sources Appendix: Regional Demographic Data Wages (ave labour force per annum), US$ PPP Population Household Spending Per Capita, US$ Private Consumption Per Capita, US$ PPP Market Size, GDP, US$bn Country Snapshot: Russia Demographic Data Section 1: Population Table: Demographic Indicators (2005) Table: Rural/Urban Breakdown Section 2: Education & Healthcare Table: Education Table: Healthcare: Vital Statistics Table: Healthcare: Expenditure Section 3: Labour Market And Spending Power Table: Employment Indicators Table: Consumption and Stratification Companies Mentioned - Berlin-Chemie/Menarini Pharma GmbH - Gedeon Richter - Krka - Lek (Novartis/Sandoz) - Verofarm For more information visit http://www.researchandmarkets.com/reports/c55702 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion